Pro-oncogenic potential of NM23-H2 in hepatocellular carcinoma

다국어 초록 (Multilingual Abstract)

NM23 is a family of structurally and functionally conserved proteins known as nucleoside diphosphate kinases (NDPK). There is abundant mRNA expression of NM23-H1, NM23-H2, or a read through transcript (NM23-LV) in the primary sites of hepatocellular carcinoma (HCC). Although the NM23-H1 protein is implicated as a metastasis suppressor, the role of NM23-H2 appears to be less understood. Thus, the aim of this study was to examine whether NM23-H2 is associated with hepatocarcinogenesis. The level of NM23-H2 expression in tumor tissues and the surrounding matrix appeared to be independent of etiology and tumor differentiation. Its subcellular localization was confined to mainly the cytoplasm and to a lesser extent in the nucleus. Ectopic expression of NM23-H2 in NIH3T3 fibroblasts and HLK3 hepatocytes showed a transformed morphology, enhanced focus formation, and allowed anchorage-independent growth.
Finally, NIH3T3 fibroblasts and HLK3 hepatocytes stably expressing NM23-H2 produced tumors in athymic mice and showed c-Myc over-expression. In addition,NF-κB and cyclin D1 expression were also increased by NM23-H2. Lentiviral delivery of NM23-H2 shRNA inhibited tumor growth of xenotransplanted tumors produced from HLK3 cells stably expressing NM23-H2.
Collectively, these results indicate that NM23-H2 may be pro-oncogenic in hepatocarcinogenesis.

참고문헌 (Reference)

1 Land H, "Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes" 304 : 596-602, 1983

2 Murakami H, "Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis" 53 : 1719-1723, 1993

3 Lascu I, "The catalytic mechanism of nucleoside diphosphate kinases" 32 : 237-246, 2000

4 Postel EH, "Targeted deletion of Nm23/nucleoside diphosphate kinase A and B reveals their requirement for definitive erythropoiesis in the mouse embryo" 238 : 775-787, 2009

5 Bosnar MH, "Subcellular localization of A and B Nm23/NDPK subunits" 298 : 275-284, 2004

6 Postel EH, "Structurebased mutational and functional analysis identify human NM23-H2 as a multifunctional enzyme" 41 : 6330-6337, 2002

7 Bromberg JF, "Stat3 as an oncogene" 98 : 295-303, 1999

8 El-Serag HB, "Rising incidence of hepatocellular carcinoma in the United States" 340 : 745-750, 1999

9 Tokunaga Y, "Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer" 19 : 66-71, 1993

10 Rosengard AM, "Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development" 342 : 177-180, 1989

11 Wu Y, "Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors" 21 : 1518-1526, 2002

12 Valentijn LJ, "Read-through transcript from NM23-H1 into the neighboring NM23-H2 gene encodes a novel protein, NM23-LV" 87 : 483-489, 2006

13 Edmondson HA, "Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies" 7 : 462-503, 1954

14 Keim DR, "PCNA levels in neuroblastoma are increased in tumors with an amplified N-myc gene and in metastatic stage tumors" 11 : 83-90, 1993

15 Venturelli D, "Overexpression of DR-nm23, a protein encoded by a member of the nm23 gene family, inhibits granulocyte differentiation and induces apoptosis in 32Dc13 myeloid cells" 92 : 7435-7439, 1995

16 Di L, "Nucleoside diphosphate kinase B knock-out mice have impaired activation of the K+ channel KCa3.1, resulting in defective T cell activation" 285 : 38765-38771, 2010

17 Steeg PS, "Nm23 and breast cancer metastasis" 25 : 175-187, 1993

18 Rayner K, "NM23-H2, an estrogen receptor beta-associated protein, shows diminished expression with progression of atherosclerosis" 292 : R743-R750, 2007

19 Dexheimer TS, "NM23-H2 may play an indirect role in transcriptional activation of c-myc gene expression but does not cleave the nuclease hypersensitive element III1" 8 : 1363-1377, 2009

20 Caligo MA, "NM23 gene expression correlates with cell growth rate and S-phase" 60 : 837-842, 1995

21 Bevilacqua G, "NM23 gene expression and human breast cancer metastases" 38 : 774-775, 1990

22 Dearolf CR, "Molecular consequences of awdb3, a cell-autonomous lethal mutation of Drosophila induced by hybrid dysgenesis" 129 : 169-178, 1988

23 Shachaf CM, "MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer" 431 : 1112-1127, 2004

24 Joosten M, "Large-scale identification of novel potential disease loci in mouse leukemia applying an improved strategy for cloning common virus integration sites" 21 : 7247-7255, 2002

25 Arnaud-Dabernat S, "Knockout mice as model systems for studying nm23/NDP kinase gene functions. Application to the nm23-M1 gene" 35 : 19-30, 2003

26 Kantor JD, "Inhibition of cell motility after nm23 transfection of human and murine tumor cells" 53 : 1971-1973, 1993

27 Boissan M, "Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma" 97 : 836-845, 2005

28 Ohneda K, "Increased expression of nucleoside diphosphate kinases/nm23 in human diploid fibroblasts transformed by SV40 large T antigen or 60Co irradiation" 348 : 273-277, 1994

29 Stahl JA, "Identification of a second human nm23 gene, nm23-H2" 51 : 445-449, 1991

30 Postel EH, "Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis" 261 : 478-480, 1993

31 Srivastava S, "Histidine phosphorylation of the potassium channel KCa3.1 by nucleoside diphosphate kinase B is required for activation of KCa3.1 and CD4 T cells" 24 : 665-675, 2006

32 Hailat N, "High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification" 88 : 341-345, 1991

33 Okuda K, "Hepatocellular carcinoma" 32 : 225-237, 2000

34 Schafer DF, "Hepatocellular carcinoma" 353 : 1253-1257, 1999

35 Tannapfel A, "Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis" 440 : 345-352, 2002

36 Yamaguchi A, "Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma" 73 : 2280-2284, 1994

37 Nakayama T, "Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product" 84 : 1349-1354, 1992

38 Steeg PS, "Evidence for a novel gene associated with low tumor metastatic potential" 80 : 200-204, 1988

39 Bosch FX, "Epidemiology of primary liver cancer" 19 : 271-285, 1999

40 Simile MM, "Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells" 25 : 333-341, 2004

41 Postel EH, "Catalysis of DNA cleavage and nucleoside triphosphate synthesis by NM23-H2/NDP kinase share an active site that implies a DNA repair function" 97 : 14194-14199, 2000

42 Cox AD, "Biological assays for cellular transformation" 238 : 277-294, 1994

43 Okabe-Kado J, "A new function of Nm23/NDP kinase as a differentiation inhibitory factor, which does not require it's kinase activity" 363 : 311-315, 1995

44 Wei SJ, "12-O-tetradecanoylphorbol-13-acetate and UV radiationinduced nucleoside diphosphate protein kinase B mediates neoplastic transformation of epidermal cells" 279 : 5993-6004, 2004